Skip to content

Feasibility and safety of endometrial curretage surgery for early endometrial cancer using manual vacuum aspiration

Feasibility and safety of endometrial curretage surgery for early endometrial cancer using manual vacuum aspiration (MVA)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1062210060
Enrollment
5
Registered
2021-12-12
Start date
2023-07-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer Endometrial cancer

Interventions

Endometrial cancer tissue is aspirated and collected using manual vacuum aspiration (MVA).

Sponsors

Ogawa Chikako
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Those who can obtain written consent from their own involuntary research participation 2. Early-stage endometrial cancer (atypical endometrial hyperplasia and early-stage endometrial cancer (endometrioid carcinoma G1/2) )who wish to be pregnant 3. Preoperative diagnostic imaging tests have confirmed no endometrial muscular invasion or lymph node metastasis 4. 20 to 40 years at the time of registration 5. General status is 0 or 1 6. No previous history of radiation therapy, chemotherapy, or surgery 7. Those with major organ functions Neutrophil count 2000 / mm3 or more , Hemoglobin 10g / dl or more (correction by blood transf usion is permitted) , Platelet count 100,000 / mm3 or more , Total bilirubin 1.5mg / dl AST (GOT) a nd ALT (GPT) 100 IU / l or lessSerum creatinine 1.2 mg / dl or less 8. The following tests must be performed within 28 days prior to the operation,The ECG test should not show normal or abnormal finding s requiringtreatment.

Exclusion criteria

Exclusion criteria: 1. Those with active double cancer (other cancers) 2. Underwent endometrial scraping with endometrial cancer 3. Diagnosed with antiphospholipid antibody syndrome and thrombosis

Design outcomes

Primary

MeasureTime frame
Endometrium removal rate by vacuum aspiration (%)

Secondary

MeasureTime frame
Uterine perforation rate Operation time Bleeding volume Adverse events and side effects that occurred from the start of vacuum aspiration to the end of post-observation Confirmation of histology

Contacts

Public ContactChikako Ogawa

Okayama University Hospital

c.fukushima@cc.okayama-u.ac.jp+81-86-235-7320

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026